Prognostic impact of prostate‐specific membrane antigen positron emission tomography (PSMA PET) staging for clinically node‐positive prostate cancer

Author:

Leow Boon Yang Jerome1ORCID,Eade Thomas12,Hruby George2ORCID,Lieng Hester1,Hsiao Edward3,Brown Chris24,Kneebone Andrew12ORCID

Affiliation:

1. Central Coast Cancer Centre Gosford Hospital Gosford New South Wales Australia

2. Northern Sydney Cancer Centre, Radiation Oncology Unit Royal North Shore Hospital Sydney New South Wales Australia

3. Department of Nuclear Medicine and PET Royal North Shore Hospital Sydney New South Wales Australia

4. National Health and Medical Research Council, Clinical Trials Centre The University of Sydney Sydney New South Wales Australia

Abstract

AbstractIntroductionIn the current American Joint Committee on Cancer staging system, patients with pelvic nodal metastases are considered stage IV prostate cancer. This study aims to investigate whether men with prostate‐specific membrane antigen positron emission tomography (PSMA PET)‐detected pelvic node‐positive prostate cancer at diagnosis have a better outcome compared to men with node‐positive disease identified on conventional imaging.MethodsThis is a retrospective cohort study comparing the outcomes of men with node‐positive prostate cancer and disease confined to the pelvis, staged with conventional versus PSMA PET imaging. Men had to be treated definitively with a combination of androgen deprivation therapy and radiation treatment to the prostate and pelvic lymph nodes. Kaplan–Meier and Cox regression analysis was used to compare biochemical failure‐free survival (BFFS) and overall survival (OS).ResultsSeventy‐six men with nodal metastases confined to the pelvis were identified. Fifty‐one were detected with PSMA PET while 25 were staged with conventional imaging. PSMA PET staged patients had a lower proportion of Gleason 8–10 disease (78% vs. 96%) as well as a lower median prostate‐specific antigen (11 ng/mL vs. 26 ng/mL). BFFS at 4 years was 72% with PSMA PET‐detected node‐positive disease vs. 38% with conventionally detected node‐positive disease. Four‐year OS was 93% with PSMA PET staged patients vs. 76% with conventionally staged patients. On multivariate analysis, the PSMA PET staged group was associated with improved BFFS (Adjusted HR = 3.00, 95% CI 1.43, 6.29, P = 0.004) and OS (Adjusted HR = 5.81, 95% CI 1.43, 23.7, P = 0.007).ConclusionMen with PSMA PET‐detected node‐positive prostate cancer confined to the pelvis have significantly better biochemical control and survival compared to those with node‐positive pelvic disease identified through conventional staging.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3